Retrospective study of post-treatment 131I SPECT/CT imaging for personalizing therapy of patients with differentiated thyroid cancer
Introduction: The absence of anatomical landmarks in the whole body scan makes it challenging to precisely localize 131I uptake, which is used to treat patients with differentiated thyroid cancer (DTC). Recently, SPECT/CT studies have been utilized to increase the diagnostic sensitivity and specific...
Saved in:
Main Authors: | Sonya Sergieva, Teodor Sofiyanski, Bozhil Robev, Milena Dimcheva, Albena Fakirova |
---|---|
Format: | Article |
Language: | English |
Published: |
Pensoft Publishers
2024-12-01
|
Series: | Folia Medica |
Online Access: | https://foliamedica.bg/article/139177/download/pdf/ |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Count-rate management in 131I SPECT/CT calibration
by: Staffan Jacobsson Svärd, et al.
Published: (2025-01-01) -
Resveratrol Sensitizes Selectively Thyroid Cancer Cell to 131-Iodine Toxicity
by: Seyed Jalal Hosseinimehr, et al.
Published: (2014-01-01) -
Validation of a novel method for localization of parathyroid adenomas using SPECT/CT
by: Rachelle A. LeBlanc, et al.
Published: (2018-10-01) -
PSMA PET/CT Identifies Intrapatient Variation in Salivary Gland Toxicity From Iodine-131 Therapy
by: Vineet Mohan MSc, et al.
Published: (2020-07-01) -
Nomogram models for predicting outcomes in thyroid cancer patients with distant metastasis receiving 131iodine therapy
by: Shui Jin, et al.
Published: (2025-01-01)